Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $486.12 | 8 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Dutch Ophthalmic, USA | $171.51 | 1 | $0 (2023) |
| Novartis Pharmaceuticals Corporation | $114.22 | 1 | $0 (2017) |
| Valeant Pharmaceuticals North America LLC | $73.24 | 1 | $0 (2017) |
| Alcon Laboratories Inc | $67.50 | 2 | $0 (2018) |
| Shire North American Group Inc | $24.45 | 1 | $0 (2017) |
| Amgen Inc. | $18.95 | 1 | $0 (2024) |
| GlaxoSmithKline, LLC. | $16.25 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $18.95 | 1 | Amgen Inc. ($18.95) |
| 2023 | $171.51 | 1 | Dutch Ophthalmic, USA ($171.51) |
| 2018 | $67.50 | 2 | Alcon Laboratories Inc ($67.50) |
| 2017 | $228.16 | 4 | Novartis Pharmaceuticals Corporation ($114.22) |
All Payment Transactions
8 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/04/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $18.95 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/06/2023 | Dutch Ophthalmic, USA | EVA, combined machine (Device), TISSUEBLUE | Food and Beverage | In-kind items and services | $171.51 | General |
| Category: Ophthalmology | ||||||
| 10/04/2018 | Alcon Laboratories Inc | DAILIES (Device) | Food and Beverage | In-kind items and services | $22.50 | General |
| Category: Ophthalmology | ||||||
| 01/15/2018 | Alcon Laboratories Inc | Centurion (Device), ORA, ReSTOR | Food and Beverage | In-kind items and services | $45.00 | General |
| Category: Ophthalmology | ||||||
| 10/05/2017 | Shire North American Group Inc | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $24.45 | General |
| Category: OPTHALMICS | ||||||
| 06/14/2017 | GlaxoSmithKline, LLC. | BREO (Drug) | Food and Beverage | In-kind items and services | $16.25 | General |
| Category: RESPIRATORY | ||||||
| 05/26/2017 | Novartis Pharmaceuticals Corporation | — | Food and Beverage | In-kind items and services | $114.22 | General |
| 01/16/2017 | Valeant Pharmaceuticals North America LLC | LOTEMAX GEL (Drug), PROLENSA | Food and Beverage | In-kind items and services | $73.24 | General |
| Category: OPHTHALMOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,333 | 1,403 | $539,600 | $120,005 |
| 2022 | 16 | 1,274 | 1,347 | $530,015 | $119,237 |
| 2021 | 18 | 1,185 | 1,273 | $468,557 | $114,078 |
| 2020 | 16 | 969 | 1,045 | $305,177 | $75,420 |
All Medicare Procedures & Services
69 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 431 | 443 | $186,060 | $41,507 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 158 | $56,960 | $15,544 | 27.3% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 182 | 197 | $59,100 | $14,392 | 24.4% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 53 | 53 | $55,290 | $13,355 | 24.2% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2023 | 14 | 14 | $49,320 | $9,234 | 18.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 60 | 73 | $18,250 | $5,122 | 28.1% |
| 92134 | Imaging of retina | Office | 2023 | 129 | 133 | $29,260 | $4,091 | 14.0% |
| 68840 | Probing of nasal tear duct | Office | 2023 | 19 | 20 | $13,200 | $2,605 | 19.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 12 | 13 | $6,305 | $2,012 | 31.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 20 | 20 | $7,200 | $1,748 | 24.3% |
| 92285 | Photography of content of eyes | Office | 2023 | 86 | 87 | $9,048 | $1,700 | 18.8% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 37 | 39 | $8,385 | $1,678 | 20.0% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 15 | 15 | $7,500 | $1,652 | 22.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 15 | 15 | $10,125 | $1,585 | 15.7% |
| 92133 | Imaging of optic nerve | Office | 2023 | 53 | 53 | $11,660 | $1,429 | 12.3% |
| 67800 | Removal of chronic growth of eyelid | Office | 2023 | 11 | 11 | $4,675 | $1,038 | 22.2% |
| 92081 | Exam of visual field with limited testing | Office | 2023 | 21 | 22 | $2,772 | $631.65 | 22.8% |
| 92250 | Photography of the retina | Office | 2023 | 17 | 17 | $2,890 | $501.73 | 17.4% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 20 | 20 | $1,600 | $179.45 | 11.2% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 440 | 453 | $190,260 | $42,502 | 22.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 150 | 168 | $60,100 | $17,266 | 28.7% |
| 15823 | Removal of excessive skin and fat of upper eyelid | Facility | 2022 | 19 | 19 | $65,760 | $12,222 | 18.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 134 | 158 | $39,220 | $11,208 | 28.6% |
| 67840 | Removal of growth of eyelid | Office | 2022 | 33 | 33 | $32,980 | $8,836 | 26.8% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 91 | 94 | $28,200 | $7,134 | 25.3% |
About Dr. Li-Wei Lin, M.D
Dr. Li-Wei Lin, M.D is a Ophthalmology healthcare provider based in Lexington, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/25/2006. The National Provider Identifier (NPI) number assigned to this provider is 1295781904.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Li-Wei Lin, M.D has received a total of $486.12 in payments from pharmaceutical and medical device companies, with $18.95 received in 2024. These payments were reported across 8 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($486.12).
As a Medicare-enrolled provider, Lin has provided services to 4,761 Medicare beneficiaries, totaling 5,068 services with total Medicare billing of $428,741. Data is available for 4 years (2020–2023), covering 69 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Lexington, MA
- Active Since 05/25/2006
- Last Updated 04/09/2012
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1295781904
Products in Payments
- EVA, combined machine (Device) $171.51
- LOTEMAX GEL (Drug) $73.24
- Centurion (Device) $45.00
- XIIDRA (Drug) $24.45
- DAILIES (Device) $22.50
- TEPEZZA (Biological) $18.95
- BREO (Drug) $16.25
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Lexington
Dr. John Kitchens, M.d, M.D
Ophthalmology — Payments: $1.2M
Dr. Jeremy Kieval, M.d, M.D
Ophthalmology — Payments: $354,855
Gary Wortz, Md, MD
Ophthalmology — Payments: $195,872
Blake Isernhagen, Md, MD
Ophthalmology — Payments: $188,723
Dr. Bruce Koffler, Md, MD
Ophthalmology — Payments: $100,236
Kunal Kanitkar, M.d, M.D
Ophthalmology — Payments: $75,249